PMID: 18047735

Turnbull EL, Rosser MF, Cyr DM
The role of the UPS in cystic fibrosis.
BMC Biochem. 2007 Nov 22;8 Suppl 1:S11., [PubMed]
Sentences
No. Mutations Sentence Comment
34 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 18047735:34:68
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 18047735:34:76
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly91Arg
X
ABCC7 p.Gly91Arg 18047735:34:85
status: NEW
view ABCC7 p.Gly91Arg details
Other identified class II disease-causing mutations in CFTR include N1303K, G85E and G91R [18]. Login to comment
36 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 18047735:36:104
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly91Arg
X
ABCC7 p.Gly91Arg 18047735:36:113
status: NEW
view ABCC7 p.Gly91Arg details
The exact mechanism by which these mutations disrupt folding is not completely clear [21], but both the G85E and G91R mutations have been shown to affect folding due to the insertion of a charged residue in the plane of the lipid bilayer [9]. Login to comment
141 ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 18047735:141:132
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 18047735:141:141
status: NEW
view ABCC7 p.Asn1303Lys details
Promisingly, the activities of 'Corr` correctors are specific for ΔF508 CFTR in HBE cells and did not affect the CFTR mutants P574H or N1303K, or the dopamine receptor mutant [82]. Login to comment
145 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 18047735:145:117
status: NEW
view ABCC7 p.Gly551Asp details
For example, the potentiator VRT-532 was able to potentiate ion channel activity in the CFTR mutants ΔF508 and G551D, inferring its potential as a drug treatment for CF patients in combination with VRT-325 [81]. Login to comment